Parameter | Correlation | Study design | First author [ref.] |
Ventricular mass index | Survival | Prospective, single centre; n=40 overall, n=28 with PAH at rest | Hagger [46] |
Indexed right ventricular mass | Mortality | Prospective, single centre; n=74 | Bradlow [47] |
Right ventricular dilatation | Mortality | Prospective, multicentre; n=64 | van Wolferen [48] |
Stroke volume | Mortality | Prospective, multicentre; n=64 | van Wolferen [48] |
RVEF | Mortality | Prospective, multicentre; n=64 | van Wolferen [48] |
Myocardial fibrosis (late gadolinium enhancement)/RVEF | Major adverse clinical events (hospitalisation, death and referral/need for lung transplantation) | Retrospective, single centre; n=21 | Soma [49] |
RVEF: right ventricular ejection fraction.